SKYE
Ticker
Skye Bioscience, Inc.
SKYE · Healthcare · Skye Bioscience, Inc., a clinical-stage biotechnology company, develops molecules that modulate G-protein-coupled receptors to treat obesit…Skye Bioscience, Inc. (SKYE), in the Healthcare sector, has 2 disclosed filings on Paydirt over the trailing twelve months from 2 corporate insiders: 0 purchases and 2 sales. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed Sep 23 and filed Sep 24. The most active filer was 5AM Partners VII, LLC with 1 filing. Data as of Nov 8 2026.
Add to watchlistFilings, ttm
2
0 buys · 2 sells
Traders, ttm
2
2 insiders
Volume, ttmiDollar value disclosed in the window
$370K
estimated for Congress, as filed for insiders
Median delay
1d
execution to disclosure
Last traded
Sep 23
Filed Sep 24
ADViAverage daily dollar volume
$146K
market data
Share price · 12M
$1.61 (-85.8%)
Adjusted for splits and dividends.
Volume by month
Buys $0
Sells $2.1M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed · past 24 months
KARecent filings
Andrew J. SchwabSALE
Director
$185K114,851 sh × $1.61
Exec Sep 23
Filed Sep 24 · 4:31 PM ET 5AM Partners VII, LLCSALE 10% owner $185K
114,851 sh × $1.61
Exec Sep 23
Filed Sep 24 · 4:29 PM ET Scott M RocklageSALE 10% owner $770K
222,621 sh across 2 lots
Exec Aug 21 2025
Filed Aug 22 2025 · 5:30 PM ET Andrew J. SchwabSALE Director $770K
222,621 sh across 2 lots
Exec Aug 21 2025
Filed Aug 22 2025 · 5:30 PM ET Kaitlyn ArsenaultSALE Chief Financial Officer $215K
43,026 sh × $4.99
Exec Nov 18 2024
Filed Feb 28 2025 · 5:30 PM ET † Paul A. GraysonSALE Director $430K
86,244 sh × $4.99
Exec Nov 18 2024
Filed Nov 19 2024 · 5:30 PM ET Punit DhillonSALE Chief Executive Officer $412K
82,546 sh × $4.99
Exec Nov 18 2024
Filed Nov 19 2024 · 5:30 PM ET Kaitlyn ArsenaultSALE Chief Financial Officer $216K
43,206 sh × $4.99
Exec Nov 18 2024
Filed Nov 19 2024 · 5:30 PM ET